Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$4.39 - $6.36 $415,961 - $602,622
-94,752 Reduced 99.8%
188 $0
Q1 2024

May 08, 2024

BUY
$5.3 - $7.61 $260,781 - $374,442
49,204 Added 107.58%
94,940 $538,000
Q4 2023

Feb 05, 2024

SELL
$4.5 - $7.51 $655,861 - $1.09 Million
-145,747 Reduced 76.11%
45,736 $302,000
Q3 2023

Nov 13, 2023

SELL
$7.85 - $10.68 $124,995 - $170,057
-15,923 Reduced 7.68%
191,483 $1.53 Million
Q2 2023

Aug 10, 2023

BUY
$9.23 - $11.23 $1.15 Million - $1.4 Million
124,787 Added 151.04%
207,406 $2.1 Million
Q1 2023

May 09, 2023

BUY
$9.41 - $12.03 $156,093 - $199,553
16,588 Added 25.12%
82,619 $879,000
Q4 2022

Feb 08, 2023

SELL
$6.5 - $11.5 $161,063 - $284,958
-24,779 Reduced 27.29%
66,031 $759,000
Q3 2022

Nov 04, 2022

BUY
$7.36 - $9.15 $668,361 - $830,911
90,810 New
90,810 $772,000

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $51.7M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.